ILMN:NASDAQ
Illumina Inc
$203.92
arrow_upward
+1.32%(+2.65) 1D
Sep 11, 10:06:35 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$201.81
High
$207.93
Low
$200.01
Mkt. cap
30.77B
Avg. vol.
1.98M
Volume
166.48K
P/E ratio
37.87
52-wk high
$231.81
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
Open
$201.81
High
$207.93
Low
$200.01
Mkt. cap
30.77B
Avg. vol.
1.98M
Volume
166.48K
P/E ratio
37.87
52-wk high
$231.81
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
News Corp
·
16 hours ago
Illumina Inc. stock outperforms competitors despite losses on the day
Benzinga
·
1 day ago
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
ad-hoc-news.de
·
1 day ago
Illumina stock heads into the open after a 2.1 percent slip
Kalkine Media
·
1 day ago
Illumina CTO Steven Barnard Sells 408 Shares at $211.06 Each
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com